These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30815771)

  • 1. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.
    Najafi Z; Sharifi M; Javadi G
    J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.
    Nedaeinia R; Sharifi M; Avan A; Kazemi M; Rafiee L; Ghayour-Mobarhan M; Salehi R
    Cancer Gene Ther; 2016 Aug; 23(8):246-53. PubMed ID: 27364574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma.
    Najafi Z; Sharifi M; Javadi G
    Cancer Gene Ther; 2015 Nov; 22(11):530-5. PubMed ID: 26427512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 5. miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
    Kaur R; Kanthaje S; Taneja S; Dhiman RK; Chakraborti A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
    Grossi I; Arici B; Portolani N; De Petro G; Salvi A
    Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5.
    Liu T; Zhang X; Sha K; Liu X; Zhang L; Wang B
    Cell Prolif; 2015 Jun; 48(3):330-7. PubMed ID: 25818666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY; Hu M; Zhao L; Guo WS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
    Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
    Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
    Long J; Jiang C; Liu B; Fang S; Kuang M
    Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-23b functions as an oncogene and activates AKT/GSK3β/β-catenin signaling by targeting ST7L in hepatocellular carcinoma.
    Zhuang L; Wang X; Wang Z; Ma X; Han B; Zou H; Wu Z; Dong S; Qu Z; Zang Y; Wu L
    Cell Death Dis; 2017 May; 8(5):e2804. PubMed ID: 28518144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-20a inhibition using locked nucleic acid (LNA) technology and its effects on apoptosis of human macrophages infected by Toxoplasma gondii RH strain.
    Rezaei F; Daryani A; Sharifi M; Sarvi S; Jafari N; Pagheh AS; Hashemi N; Hejazi SH
    Microb Pathog; 2018 Aug; 121():269-276. PubMed ID: 29800695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
    Wang K; Liang Q; Wei L; Zhang W; Zhu P
    Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MicroRNA-30a inhibits proliferation of hepatocellular carcinoma cells via targeted regulation of forkhead-box protein A1].
    Li Y; Fu L; Fu XY; Li RH; Peng SF
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):706-711. PubMed ID: 29108194
    [No Abstract]   [Full Text] [Related]  

  • 17. microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
    He L; Meng D; Zhang SH; Zhang Y; Deng Z; Kong LB
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1060-1067. PubMed ID: 29777702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
    He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
    Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4.
    Nedaeinia R; Sharifi M; Avan A; Kazemi M; Nabinejad A; Ferns GA; Ghayour-Mobarhan M; Salehi R
    Tumour Biol; 2017 Mar; 39(3):1010428317692261. PubMed ID: 28347230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.